Send to printer »

GEN News Highlights : May 16, 2013

Quest Acquires Concentra’s Toxicology, Clinical Lab Business

Quest Diagnostics today said it has acquired the toxicology and clinical laboratory business of Humana subsidiary Concentra. Further, Quest has agreed to be Concentra’s primary provider of workplace drug toxicology and clinical lab testing. Financial terms were not disclosed.

"With this transaction, Concentra's patients, physicians, and employer clients will gain access to Quest's industry-leading menu of innovative workplace drug and clinical lab diagnostic information services," Steve Rusckowski, Quest president and CEO, said in a statement.

Under the terms of the agreements, Quest has acquired the assets of Concentra's Memphis, TN-based Advanced Toxicology Network (ATN) lab business, and will provide Concentra and its employer clients and clinical laboratory testing services to patients and physicians in Concentra's network of primary care and urgent care facilities.

Quest added that the ATN business will be transitioned into its national lab network by the end of this year.